Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Jun;20(6):1573-1579.
doi: 10.1111/jocd.14104. Epub 2021 Apr 3.

How does COVID-19 impact psoriasis practice, prescription patterns, and healthcare delivery for psoriasis patients? A cross-sectional survey study

Mohamed H M El-Komy  1   2 , Asmaa Abdelnaby  3 , Mona El-Kalioby  1   2
Affiliations
Observational Study

How does COVID-19 impact psoriasis practice, prescription patterns, and healthcare delivery for psoriasis patients? A cross-sectional survey study

Mohamed H M El-Komy et al. J Cosmet Dermatol. 2021 Jun.

Abstract

Background: Psoriasis is a chronic skin disease that needs continuous medical care. During COVID-19, delivering medical service was negatively affected.

Aims: To describe the impact of COVID-19 on psoriasis healthcare delivery, management, and practice.

Methods: This observational cross-sectional study was conducted on 197 dermatologists using a validated online questionnaire. The survey evaluated the effect of COVID-19 on the decisions, prescription patterns, appointments rescheduling, and healthcare delivery for psoriasis patients by dermatologists. The questionnaire was developed and validated with a reliability score >0.7.

Results: During the pandemic, most dermatologists delayed initiating biological/immunosuppressive therapy for psoriasis unless urgently needed by the patient. For patients already receiving biologics or immunosuppressive treatment, most dermatologists favored continuation of therapy. Almost half (44.2%) of participants do not perform SARS-CoV-2 PCR screening before initiating biologics/immunosuppressive therapy. Dermatologists also reported an increased prescription of topical medications (79.2%), natural sunlight (28.4%), acitretin (26.9%), and home UVB (21.3%). Opinions regarding the use of hydroxychloroquine for COVID-19 treatment/prophylaxis for psoriasis patients were controversial. Intervals between face-to-face follow-up visits were prolonged by 71.6% of dermatologists. More than half of participants reported that their patients discontinued treatment without medical consultation. More than three fourth of responders either agreed or strongly agreed that COVID-19 negatively affected psoriasis patients.

Conclusions: The COVID-19 pandemic has a negative impact on psoriasis management and healthcare delivery. Dermatologists are cautious about using biologics and immunosuppressive drugs during the pandemic, making case-by-case decisions. Psoriasis patients need compliance monitoring, and psychological support during the pandemic, which can be facilitated by teledermatology.

Keywords: PCR; SARS-CoV-2; biologics; coronavirus; immunosuppressive; psoriasis.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to declare.

Figures

FIGURE 1
FIGURE 1
SARS‐CoV2 PCR workup by dermatologists before biological or immunosuppressive therapy initiation during the pandemic
FIGURE 2
FIGURE 2
Percentage of dermatologists reporting an increased prescription of topical medications, natural sunlight, acitretin, and home UVB during the pandemic
FIGURE 3
FIGURE 3
Percentage of dermatologists reporting the use of teledermatology during COVID‐19
FIGURE 4
FIGURE 4
Treatment received by psoriasis patients who tested positive for COVID‐19 as reported by participating dermatologists
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. World Health Organization . Timeline: WHO's COVID‐19 response. Available from. https://www.who.int/emergencies/diseases/novel‐coronavirus‐2019/interact.... Accessed December 22, 2020.
    1. Worldometer . COVID‐19 Coronavirus pandemic Update. 2020. Available from https://www.worldometers.info/coronavirus/Accessed December 22, 2020.
    1. Mostafa PIN, Hegazy AA. Dermatological consultations in the COVID‐19 era: is teledermatology the key to social distancing? an Egyptian experience. J Dermatolog Treat. 2020;7:1‐6. 10.1080/09546634.2020.1789046. - DOI - PubMed
    1. Palmer K, Monaco A, Kivipelto M, et al. The potential long‐term impact of the COVID‐19 outbreak on patients with non‐communicable diseases in Europe: consequences for healthy ageing. Aging Clin Exp Res. 2020;32:1189‐1194. - PMC - PubMed
    1. Provenzano DA, Sitzman BT, Florentino SA, et al. Clinical and economic strategies in outpatient medical care during the COVID‐19 pandemic. Reg Anesth Pain Med. 2020;45:579‐585. - PMC - PubMed

Publication types